Investors purchased shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on weakness during trading on Monday. $219.95 million flowed into the stock on the tick-up and $182.80 million flowed out of the stock on the tick-down, for a money net flow of $37.15 million into the stock. Of all equities tracked, Walgreens Boots Alliance had the 11th highest net in-flow for the day. Walgreens Boots Alliance traded down ($0.62) for the day and closed at $70.37

Several analysts have recently weighed in on WBA shares. Needham & Company LLC set a $94.00 target price on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Monday, July 17th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 3rd. UBS AG reiterated a “buy” rating and set a $96.00 target price (down from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd. Loop Capital assumed coverage on shares of Walgreens Boots Alliance in a research report on Thursday, August 24th. They set a “buy” rating and a $95.00 target price on the stock. Finally, Jefferies Group LLC reissued a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, September 7th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $87.63.

The company has a market capitalization of $71,667.88, a P/E ratio of 13.92, a price-to-earnings-growth ratio of 1.26 and a beta of 1.20. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The company had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. During the same period in the previous year, the firm posted $1.07 earnings per share. The company’s revenue was up 5.3% on a year-over-year basis. research analysts predict that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 42.33%.

Walgreens Boots Alliance announced that its board has authorized a share buyback program on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback programs are usually an indication that the company’s board of directors believes its stock is undervalued.

In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director John Anthony Lederer purchased 20,000 shares of the company’s stock in a transaction that occurred on Thursday, October 26th. The shares were acquired at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the purchase, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. Insiders own 13.50% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Commonwealth Bank of Australia grew its holdings in Walgreens Boots Alliance by 139.5% during the second quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after purchasing an additional 26,893 shares during the period. IBM Retirement Fund grew its holdings in Walgreens Boots Alliance by 88.1% during the second quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock valued at $2,004,000 after purchasing an additional 10,729 shares during the period. Andra AP fonden grew its holdings in Walgreens Boots Alliance by 35.3% during the second quarter. Andra AP fonden now owns 58,300 shares of the pharmacy operator’s stock valued at $4,565,000 after purchasing an additional 15,200 shares during the period. Schwab Charles Investment Management Inc. grew its holdings in Walgreens Boots Alliance by 5.4% during the second quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock valued at $236,476,000 after purchasing an additional 154,995 shares during the period. Finally, Birinyi Associates Inc. grew its holdings in Walgreens Boots Alliance by 9.0% during the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after purchasing an additional 750 shares during the period. 63.58% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Investors Buy Shares of Walgreens Boots Alliance, Inc. (WBA) on Weakness” was first posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/11/13/investors-buy-shares-of-walgreens-boots-alliance-inc-wba-on-weakness.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.